CellCept is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Mycophenolate Mofetil.
Product ID | 0004-0259_069ac782-5550-41a9-9179-bc1e44430526 |
NDC | 0004-0259 |
Product Type | Human Prescription Drug |
Proprietary Name | CellCept |
Generic Name | Mycophenolate Mofetil |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 1995-05-03 |
Marketing Category | NDA / NDA |
Application Number | NDA050722 |
Labeler Name | Genentech, Inc. |
Substance Name | MYCOPHENOLATE MOFETIL |
Active Ingredient Strength | 250 mg/1 |
Pharm Classes | Antimetabolite Immunosuppressant [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 1995-05-03 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA050722 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1995-05-03 |
Marketing End Date | 2015-06-30 |
Marketing Category | NDA |
Application Number | NDA050722 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1995-05-03 |
Marketing Category | NDA |
Application Number | NDA050722 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1995-05-03 |
Ingredient | Strength |
---|---|
MYCOPHENOLATE MOFETIL | 250 mg/1 |
SPL SET ID: | 37241e87-4af4-4dc3-a1aa-ea6f20d8dc40 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0004-0259 | CellCept | Mycophenolate Mofetil |
0004-0260 | CellCept | Mycophenolate Mofetil |
0004-0261 | CellCept | Mycophenolate Mofetil |
0004-0298 | CellCept | Mycophenolate Mofetil hydrochloride |
21695-171 | CellCept | CellCept |
0054-0163 | Mycophenolate Mofetil | Mycophenolate Mofetil |
0054-0166 | Mycophenolate Mofetil | Mycophenolate Mofetil |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CELLCEPT 74357234 1889130 Live/Registered |
Hoffmann-La Roche Inc 1993-02-05 |